Pharma CEOs testify on prescription drug prices at Senate hearing
epa11137172 Merck CEO Robert Davis (L) prepares to testify before the Senate Health, Education, Labor and Pensions Committee on prescription drug prices in the Dirksen Senate Office Building in Washington, DC, USA, 08 February 2024. Davis, along with and Bristol Myers Squibb CEO Davis, along with Johnson and Johnson CEO Joaquin Duato and Bristol Myers Squibb CEO Chris Boerner, testified on price discrepancies between their medicines sold in the US and abroad. EPA/JIM LO SCALZO
